Ce Rick Strattan Cyclo Therapeutics, Inc. (CYTH) insider trading activity

Ce Rick Strattan is Director of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 399,272 shares of CYTH, which is worth approximately $303,446. The most recent transaction as insider was on Feb 27, 2025, when has been sold 30,169 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 399K

8.17% 3M change

39.32% 12M change

Total Value Held $303,446

CE RICK STRATTAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 27 2025	BUY Grant, award, or other acquisition	-	30,169 Added 7.03%	399,272 Common Stock
Nov 15 2024	BUY Grant, award, or other acquisition	-	63,608 Added 14.7%	369,103 Common Stock
Aug 16 2024	BUY Grant, award, or other acquisition	-	9,524 Added 3.02%	305,495 Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	-	9,375 Added 3.07%	295,971 Common Stock
Feb 13 2024	BUY Grant, award, or other acquisition	-	6,963 Added 2.37%	286,596 Common Stock
Nov 28 2023	BUY Grant, award, or other acquisition	-	8,209 Added 2.85%	279,633 Common Stock
Oct 27 2023	BUY Grant, award, or other acquisition	-	42,599 Added 13.57%	271,424 Common Stock
Aug 18 2023	BUY Grant, award, or other acquisition	-	8,089 Added 3.41%	228,825 Common Stock
May 17 2023	BUY Grant, award, or other acquisition	-	21,360 Added 8.82%	220,736 Common Stock

CRS

Ce Rick Strattan

Director

Gainesville, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Value

Insider Trading

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cyclo Therapeutics, Inc.

Track Activities on CYTH

Account